Back
 JBM  Vol.7 No.7 , July 2019
Characterization of Dyslipidemia and Assessment of Atherogenic Risk amongst Cameroonian Living in Yaounde: A Cross Sectional Study
Abstract: Background: This study was conducted to evaluate the lipid profile in nutritional categories, to characterize dyslipidemia and assess cardiovascular risk, to describe association between anthropometric markers, incidence of dyslipidemia and cardiovascular risk in Cameroonian adults. Methods: A cross-sectional survey was conducted in Yaoundé from April 2014-June 2015. It included 1986 individuals, aged 20 - 65 years, both males (30.7%) and females (69.3%). Blood pressure, anthropometric measurement including weight, height, body fat, waist and hip circumference were performed. BMI was used to define nutritional status. Blood analysis included total cholesterol, HDL-cholesterol and triglycerides, insulin. Dyslipidemia was defined as hypercholesterolemia, hypertriglyceridemia, low HDL-cholesterolemia and combined dyslipidemia. Atherogenic indexes were calculated for assessment of the cardiovascular risk. Results: Out of the 1986 participants, 544 (27.4%), 616 (31%), and 826 (41.6%) were normal weight, overweight and obese respectively. In obese, lipid profile varied according to gender (p < 0.05). In addition, total cholesterol (p < 0.05), LDL-c (p < 0.05) level, total cholesterol/HDL-cholesterol and LDL-c/HDL-c were higher among obese than normal weight individuals. Hypercholesterolemia (19.3%), hypertriglyceridemia (11.64%), combined dyslipidemia (3.40%) and the atherogenic profile (Total cholesterol/HDL-cholesterol ratio > 5) was (40.50%). Low HDL-cholesterolemia (75.4%) was the main lipid abnormality found, independently of gender, age, fat location. Waist circumference (WC) unlike body mass index (BMI) and body fatness was associated to hypercholesterolemia. Conclusion: Low HDL-cholesterolemia and high atherogenic risk profile are more prevalent amongst Cameroonian adults. Promotion of healthy life including good eating habits shall be encouraged to reduce mortality from cardiovascular disease complications.
Cite this paper: Yangoua, H. , Azantsa, B. , Kuate, D. , Ntentie, F. , Nguedjo, M. , Nkougni, J. , Tchuente, B. , Ngondi, J. and Oben, J. (2019) Characterization of Dyslipidemia and Assessment of Atherogenic Risk amongst Cameroonian Living in Yaounde: A Cross Sectional Study. Journal of Biosciences and Medicines, 7, 35-50. doi: 10.4236/jbm.2019.77004.
References

[1]   Cappucio, F.P. and Michelle, A.M. (2016) Cardiovascular Disease and Hypertension in Sub-Saharan Africa: Burden, Risk and Interventions. Internal and Emergency Medicine, 11, 299-305.
https://doi.org/10.1007/s11739-016-1423-9

[2]   Keates, A.K., Ana, O.M., Mpiko, N., Karen, S. and Simon, S. (2017) Cardiovascular Disease in African: Epidemiological Profile and Challenges. Nature Reviews Cardiology, 14, 273-293.
https://doi.org/10.1038/nrcardio.2017.19

[3]   Osei-Yeboah, J., Owiredu, B.A., Norgbe, G.K., Lokpo, S.Y., Gyamfi, J., Allotey, E.A. and Attah, F.A. (2017) The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. International Journal of Chronic Diseases, 2017, Article ID: 8765804.
https://doi.org/10.1155/2017/8765804

[4]   Kengne, A.P., Echouffo-Tcheugui, J., Sobgnwi, E. and Mbanya, J.C. (2013) New Insights on Diabetes Mellitus and Obesity in Africa. Part 1: Prevalence, Pathogenesis and Comorbidities. Heart, 99, 979-983.
https://doi.org/10.1136/heartjnl-2012-303316

[5]   Sabir, A.A., Jimoh, A., Iwuala, S.O., Isezuo, S.A., Bilbis, L.S., Aminu, K.U., Abubakar, S.A. and Saidu, Y. (2016) Metabolic Syndrome in Urban City of North-Western Nigeria: Prevalence and Determinants. The Pan African Medical Journal, 23, 19.
https://doi.org/10.11604/pamj.2016.23.19.5806

[6]   Ntentie, F.R., Ngondi, J.L., Azantsa, K.B.G., Santy, E.V., Dimodi, H.T., Mbong, A.M.-A., et al. (2014) Urbanization and Metabolic Syndrome in Cameroon: Alertness on Less Urbanized Areas. Endocrinology and Metabolic Syndrome, 3, 2.

[7]   Azantsa, K.G.B., Ntentié, F.R., Mbong, M.A., Kengne, N.A.P., Kuaté, D., Dakam, W., Ngondi, J.L. and Oben, J. (2013) Body Mass Index, Blood Pressure and Hypertension Subtypes among Untreated Hypertensive Cameroonians. British Journal of Medicine and Medical Research, 3, 2119-2131.
https://doi.org/10.9734/BJMMR/2013/4685

[8]   Tchoubi, S., Sobngwi-Tambekou, J., Noubia, N.J.J., Asangbeh, S.L., Nkoum, B.A. and Sobngwi, E. (2015) Prevalence and Risk Factors of Overweight and Obesity among Children Aged 6-59 Months in Cameroon: A Multistage, Stratified Cluster Sampling Nationwide Survey. PLoS ONE, 10, e0143215.
https://doi.org/10.1371/journal.pone.0143215

[9]   Wamba, P.C., Oben, E.J. and Cianflone, K. (2013) Prevalence of Overweight, Obesity, and Thinness in Cameroon Urban Children and Adolescents. Journal of Obesity, 2013, Article ID: 737592.
https://doi.org/10.1155/2013/737592

[10]   Yangoua, M.C.H., Azantsa K.G.B., Ntentié, F.R., Ngondi, J.L. and Oben, J. (2010) Prevalence of Insulin Resistance in Obese Cameroonian Women. Journal of Diabetes and Endocrinology, 1, 19-26.

[11]   WHO (1998) Obesity Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. World Health Organization, Geneva.

[12]   WHO (2000) Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series, No. 894, 1-253.

[13]   Nigro, E., Scudiero, O., Monaco, M.L., Palmieri, A., Mazzarella, G., Costagliola, C., et al. (2014) New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases. BioMed Research International, 2014, Article ID: 658913.
https://doi.org/10.1155/2014/658913

[14]   Bray, G.A. and Bellanger, T. (2006) Epidemiology, Trends, and Morbidities of Obesity and the Metabolic Syndrome. Endocrine, 29, 109-117.
https://doi.org/10.1385/ENDO:29:1:109

[15]   De Lorenzo, A., Soldati, L., Sarlo, F., Calvani, M., Di Lorenzo, N. and Di Renzo, L. (2016) New Obesity Classification Criteria as a Tool for Bariatric Surgery Indication. World Journal of Gastroenterology, 2, 681-703.
https://doi.org/10.3748/wjg.v22.i2.681

[16]   Shuldiner, A.R. (2008) Obesity Genes and Gene-Environment-Behavior Interactions: Recommendations for a Way Forward. Obesity (Silver Spring), 16, 79-81.
https://doi.org/10.1038/oby.2008.523

[17]   Ge, P., Dong, C.X., Ren, X.L., Weiderpass, E., Zhang, C.J., et al. (2015) The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China. PLoS ONE, 10, e0144104.
https://doi.org/10.1371/journal.pone.0144104

[18]   Shao, H., Chen, L.Q. and Xu, J. (2011) Treatment of Dyslipidemia in the Elderly. Journal of Geriatric Cardiology, 8, 55-64.
https://doi.org/10.3724/SP.J.1263.2011.00055

[19]   Zhao, S., Wang, Y.J., Mu, Y.M., Yu, B.L., Ye, P., et al. (2014) Prevalence of Dyslipidaemia in Patients Treated with Lipid-Lowering Agents in China. International Study Atherosclerosis, 235, 463-469.
https://doi.org/10.1016/j.atherosclerosis.2014.05.916

[20]   Heymsfield, S., Peterson, C.M., Thomas, D.M., Heo, M. and Schuna, J.M. (2016) Why Are There Race/Ethnic Differences in Adult Body Mass Index-Adiposity Relationships? A Quantitative Critical Review. Obesity Reviews, 17, 262-275.
https://doi.org/10.1111/obr.12358

[21]   Pu, J., Romanelli, R., Zhao, B., Azar, K.M.J., Hastings, K.G., Nimbal, V., Fortmann, S.P. and Palaniappan, L.P. (2015) Dyslipidemia in Special Ethnic Populations. Cardiology Clinics, 33, 325-333.
https://doi.org/10.1016/j.ccl.2015.01.005

[22]   Phillips, C.M. (2013) Metabolically Healthy Obesity: Definitions, Determinants and Clinical Implications. Reviews in Endocrine and Metabolic Disorders, 14, 219-227.
https://doi.org/10.1007/s11154-013-9252-x

[23]   Monach, P.A. (2012) Repeating Tests: Different Roles in Research Studies and Clinical Medicine. Biomarkers in Medicine, 6, 691-703.
https://doi.org/10.2217/bmm.12.57

[24]   Friedwald, W.T., Levy, R.I. and Frederickson, D.S. (1972) Estimation of the Concentration of Low Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clinical Chemistry, 18, 499-502.

[25]   Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2487.
https://doi.org/10.1001/jama.285.19.2486

[26]   Onat, A., Can, G., Kaya, H. and Hergenç, G. (2010) “Atherogenic Index of Plasma” (Log10 Triglyceride/High-Density Lipoprotein-Cholesterol) Predicts High Blood Pressure, Diabetes, and Vascular Events. Journal of Clinical Lipidology, 4, 89-98.
https://doi.org/10.1016/j.jacl.2010.02.005

[27]   Dobiásová, M., Frohlich, J., Sedová, M., Cheung, M.C. and Brown, B.G. (2011) Cholesterol Esterification and Atherogenic Index of Plasma Correlate with Lipoprotein Size and Findings on Coronary Angiography. The Journal of Lipid Research, 52, 566-561.
https://doi.org/10.1194/jlr.P011668

[28]   Moor, V.J.A., Amougou, S.N., Ombotto, S., Ntone, F., Wouamba, E. and Nonga, B.N. (2017) Dyslipidemia in Patients with a Cardiovascular Risk and Disease at the University Teaching Hospital of Yaoundé, Cameroon. International Journal of Vascular Medicine, 2017, Article ID: 6061306.
https://doi.org/10.1155/2017/6061306

[29]   Niroumand, S., Mohammad, K., Majid, K.-R., Maryam, A., Mohammadreza, J., Gholamhasan, K., et al. (2015) Atherogenic Index of Plasma (AIP, A Marker of Cardiovascular Disease. Medical Journal of the Islamic Republic of Iran, 29, 240.

[30]   WHO (1995) Physical Status: The Use and Interpretation of Anthropometry. World Health Organization, Geneva.

[31]   Taga, I., Kouemeni, L. and Ngogang, Y.J. (2004) Valeurs de référence des lipides sériques chez de jeunes hommes camerounais. Note Scientifique. Annales de Biologie Clinique, 41, 33-38.

[32]   Glew, R.H., William, M., Conn, C.A., Cadena, S.M., Crossey, M., et al. (2001) Cardiovascular Disease Risk Factors and Diet of Fulani Pastoralists of Northern Nigeria. The American Journal of Clinical Nutrition, 74, 730-736.
https://doi.org/10.1093/ajcn/74.6.730

[33]   Adams-Cambel, L.L., Nwankwo, M.U., Omene, J.A., Ukoli, F.A., Young, M.P., Haile, G.T. and Kuller, L.H. (1988) Assessment of Cardiovascular Risk Factors in Nigerian Students. Arteriosclerosis, 8, 793-796.
https://doi.org/10.1161/01.ATV.8.6.793

[34]   Aguilar-Salinas, C.A., Olaiz, G., Valles, V., Ríos, T.J.M., Gómez, P.F.J., et al. (2001) High Prevalence of Low HDL Cholesterol Concentrations and Mixed Hyperlipidemia in a Mexican Nationwide Survey. The Journal of Lipid Research, 42, 1298-1307.

[35]   MacLean, D., Petrasovits, A., Connelly, P., Joffres, M., O’Connor, B. and Little, J. (1999) Plasma Lipids and Lipoprotein Reference Values, and the Prevalence of Dyslipoproteinemia in Canadian Adults. Canadian Heart Health Surveys Research Group. Canadian Journal of Cardiology, 15, 434-444.

[36]   Toth, P.P., Potter, D. and Ming, E.E. (2012) Prevalence of Lipid Abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006. Journal of Clinical Lipidology, 6, 325-330.
https://doi.org/10.1016/j.jacl.2012.05.002

[37]   Nwagha, U.I., Ikekpeazu, E.J., Ejezie, F.E., Neboh, E.E. and Maduka, I.C. (2010) Atherogenic Index of Plasma as Useful Predictor of Cardiovascular Risk among Postmenopausal Women in Enugu, Nigeria. African Health Sciences, 10, 248-252.

[38]   Souza, L.J., Souto, F.J., Souza, T.F., Reis, A.F.F., Neto, C.G., Bastos, D.A., Côrtes, A.V., Chalita, B.F.E. and Teixeira, C.L. (2003) Prevalence of Dyslipidemia and Risk Factors in Campos Dos Goytacazes, in the Brazilian State of Rio de Janeiro. Arquivos Brasileiros de Cardiologia, 81, 249-264.
https://doi.org/10.1590/S0066-782X2003001100005

[39]   Li, Z., Mcnamara, J.R., Fruchart, J.C., Luc, G., Bard, J.M., Ordovas, J.M., Wilson, P.W. and Schaefer, E.J. (1996) Effects of Gender and Menopausal Status on Plasma Lipoprotein Subspecies and Particle Sizes. The Journal of Lipid Research, 37, 1886-1896.

[40]   Smith, U. (2015) Abdominal Obesity: A Marker of Ectopic Fat Accumulation. The Journal of Clinical Investigation, 125, 1790-1792.
https://doi.org/10.1172/JCI81507

[41]   WHO (2011) Global Status Report on Non-Communicable Diseases 2010. World Health Organization, Geneva.

[42]   Azhar, W., Buczkowski, B., Smith, C. and Onambele-Pearson, G. (2018) Impact of Circulating Triglycerides Concentration on Atherosclerotic Disease Status in Middle-Aged Saudi Arabian Dwellers. Nutrients, 10, 1642.

[43]   Fezeu, L., Balkau, B., Kengne, A.-P., Sobngwi, E. and Mbanya, J.C. (2006) Metabolic Syndrome in a Sub-Saharan African Setting: Central Obesity May Be the Key Determinant. Atherosclerosis, 193, 70-76.
https://doi.org/10.1016/j.atherosclerosis.2006.08.037

[44]   Chehrei, A., Sadrnia, S., Keshteli, H.A., Daneshmand, A.M. and Rezaei, J. (2007) Correlation of Dyslipidemia with Waist to Height Ratio, Waist Circumference, and Body Mass Index in Iranian Adults. Asia Pacific Journal of Clinical Nutrition, 16, 248-253.

[45]   Lin, Y., Mousa, S.S., Elshourbagy, N. and Mousa, S.A. (2010) Current Status and Future Directions in Lipid Management: Emphasizing Low-Density Lipoproteins, High-Density Lipoproteins, and Triglycerides as Targets for Therapy. Vascular Health and Risk Management, 6, 73-85.
https://doi.org/10.2147/VHRM.S8725

[46]   Alwaili, K., Awan, Z., Alshahrani, A. and Genest, J. (2010) High-Density Lipoproteins and Cardiovascular Disease: 2010 Update. Expert Review of Cardiovascular Therapy, 8, 413-423.
https://doi.org/10.1586/erc.10.4

[47]   Degoma, E.M., Leeper, N.J. and Heidenreich, P.A. (2008) Clinical Significance of High-Density Lipoprotein Cholesterol in Patients with Low-Density Lipoprotein Cholesterol. Journal of the American College of Cardiology, 51, 49-55.
https://doi.org/10.1016/j.jacc.2007.07.086

[48]   Millan, J., Xavier, P., Muñoz, A., Zuñiga, M., Rubies-Prat, J., Felipe, P., et al. (2009) Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention. Vascular Health and Risk Management, 5, 757-765.
https://doi.org/10.2147/VHRM.S6269

[49]   Lewis, B., Assmann, G., Tikkanen, M., Mancini, M. and Pometta, D. (1992) Prevention of Coronary Heart Disease: Scientific Background and New Clinical Guidelines. Recommendations of the European Atherosclerosis Society, Prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutrition, Metabolism and Cardiovascular Diseases, 2, 113-156.

[50]   Mudhaffar, S.K. (2013) Atherogenic Index of Plasma (AIP) as a Parameter in Predicting Cardiovascular Risk in Males Compared to the Conventional Dyslipidemic Indices (Cholesterol Ratios). Karbala Journal of Medicine, 6, 1506-1513.

[51]   Zhu, X., Yu, L., Hui, Z., Qinhua, M., Xiaohua, Z., Ting, L., et al. (2018) Atherogenic Index of Plasma Is a Novel and Better Biomarker Associated with Obesity: A Population-Based Cross-Sectional Study in China. Lipids in Health and Disease, 17, 37.
https://doi.org/10.1186/s12944-018-0686-8

[52]   Cai, G., Shi, G., Xue, S. and Lu, W. (2017) The Atherogenic Index of Plasma Is a Strong and Independent Predictor for Coronary Artery Disease in the Chinese Han Population. Medicine (Baltimore), 96, e8058.
https://doi.org/10.1097/MD.0000000000008058

[53]   Soriguer, F., Gutierrez-Repiso, C., Rubio-Martin, E., García-Fuentes, E., Almaraz, M.C., Colomo, N., et al. (2013) Metabolically Healthy But Obese, a Matter of Time? Findings from the Prospective Pizarra Study. The Journal of Clinical Endocrinology & Metabolism, 98, 2318-2325.
https://doi.org/10.1210/jc.2012-4253

[54]   Appleton, S.L., Seaborn, C.J., Visvanathan, R., Hill, C.L., Gill, T.K. and Taylor, A.W. (2013) Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype: A Cohort Study. Diabetes Care, 36, 2388-2394.
https://doi.org/10.2337/dc12-1971

[55]   Hwang, Y.C., Hayashi, T., Fujimoto, W.Y., Kahn, S.E., Leonetti, D.L., Mcneely, M.J. and Boyko, E.J. (2015) Visceral Abdominal Fat Accumulation Predicts the Conversion of Metabolically Healthy Obese Subjects to an Unhealthy Phenotype. International Journal of Obesity, 39, 1365-1370.
https://doi.org/10.1038/ijo.2015.75

[56]   Rosenson, R.S. (2005) Low HDL-C: A Secondary Target of Dyslipidemia Therapy. The American Journal of Medicine, 118, 1067-1077.
https://doi.org/10.1016/j.amjmed.2004.12.021

[57]   Rutherford, J.N., Mcdade, T.W., Feranil, A.B., Adair, L.S. and Kuzawa, C.W. (2010) High Prevalence of Low HDL-c in the Philippines Compared to the US: Population Differences in Associations with Diet and BMI. Asia Pacific Journal of Clinical Nutrition, 19, 57-67.

 
 
Top